News & Events about Heron Therapeutics Inc.
Heron Therapeutics Announces Commercial Leadership Changes Heron Therapeutics Announces Commercial Leadership Changes PR Newswire SAN DIEGO, April 20, 2023 SAN DIEGO, April 20, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ('Heron'), a commercial-stage biotechnology company...
Fool.com Headlines
2 months ago
The stock has been rising since the company appointed a new CEO.Shares of Heron Therapeutics (NASDAQ: HRTX) were up more than 19% early Thursday afternoon. The biopharmaceutical company, which has been focusing on post-surgery therapeutics, has been on a steady rise since the company announced on ...
Heron Therapeutics Announces New CEO and Board Chairman Heron Therapeutics Announces New CEO and Board Chairman PR Newswire SAN DIEGO, April 3, 2023 Craig Collard Appointed CEO Adam Morgan Named Chairman of the Board SAN DIEGO, April 3, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (NASDAQ:HRTX...
Heron Therapeutics Announces U.S. Commercial Launch of APONVIE for the Management of Postoperative Nausea and Vomiting in Adults Heron Therapeutics Announces U.S. Commercial Launch of APONVIE for the Management of Postoperative Nausea and Vomiting in Adults PR Newswire SAN DIEGO, March 6, 2023...
Heron Therapeutics Highlights Progress in Acute Care and Oncology Care Franchises Heron Therapeutics Highlights Progress in Acute Care and Oncology Care Franchises PR Newswire SAN DIEGO, Jan. 9, 2023 - Preliminary Annual Net Product Sales Across the Company Grew 24% to $106.7 Million in 2022...